AGP Executive Report
Last update: 4 hours agoSleep and CBD: A new review says many people use cannabis for insomnia, but research has yet to show whether it reliably improves sleep quality or restorative sleep stages. Hemp Rules: Wisconsin advocates warn that federal THC limits due Dec. 11 could affect legal CBD products containing trace THC, and argue for safeguards such as testing and accurate labels instead of a broad ban. Pain Research: U.S. clinical trials are underway for VER-01, a cannabis extract for chronic back pain. If approved, it could become the first cannabis-based pain medication authorized in the country. Heart Health: A new study links recreational cannabis legalization with rising heart-attack admissions, though the reported association does not establish cause and effect.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.